Literature DB >> 32641910

A Review of the Current Treatment of Tourette Syndrome.

Mary F Seideman, Travis A Seideman.   

Abstract

Tourette syndrome is a hyperkinetic movement disorder that presents before age 18 years and involves motor and phonic tics that may present with a wide range of severity. The severity and presentation of tics in an individual may fluctuate over time. Tourette syndrome may affect social relationships and school attendance, and may result in depression. Comorbidities are common, with attention-deficit/hyperactivity disorder and obsessive-compulsive disorder being most common. The literature supporting optimal treatment is limited but provides a framework for clinical decision-making. The focus of this review is to discuss the symptoms and possible causes of Tourette syndrome and current non-pharmacologic and pharmacologic treatment options, to help practitioners optimize care for pediatric patients with this disease. Copyright Pediatric Pharmacy Association. All rights reserved. For permissions, email: mhelms@pediatricpharmacy.org.

Entities:  

Keywords:  Tourette syndrome; behavioral therapy; pediatrics; pharmacotherapy; tics

Year:  2020        PMID: 32641910      PMCID: PMC7337131          DOI: 10.5863/1551-6776-25.5.401

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  5 in total

Review 1.  Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain.

Authors:  Hao-Ming Xu; Hong-Li Huang; You-Lian Zhou; Hai-Lan Zhao; Jing Xu; Di-Wen Shou; Yan-Di Liu; Yong-Jian Zhou; Yu-Qiang Nie
Journal:  Gastroenterol Res Pract       Date:  2021-01-16       Impact factor: 2.260

Review 2.  Efficacy of Behavioural Intervention, Antipsychotics, and Alpha Agonists in the Treatment of Tics Disorder in Tourette's Syndrome.

Authors:  Muneeba Rizwan; Noor Ul Ain Shahid; Noreen Naguit; Rakesh Jakkoju; Sadia Laeeq; Tiba Reghefaoui; Hafsa Zahoor; Ji Hyun Yook; Lubna Mohammed
Journal:  Cureus       Date:  2022-02-21

Review 3.  European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment.

Authors:  Veit Roessner; Heike Eichele; Jeremy S Stern; Liselotte Skov; Renata Rizzo; Nanette Mol Debes; Péter Nagy; Andrea E Cavanna; Cristiano Termine; Christos Ganos; Alexander Münchau; Natalia Szejko; Danielle Cath; Kirsten R Müller-Vahl; Cara Verdellen; Andreas Hartmann; Aribert Rothenberger; Pieter J Hoekstra; Kerstin J Plessen
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-11-10       Impact factor: 4.785

4.  Medical Cannabis for Gilles de la Tourette Syndrome: An Open-Label Prospective Study.

Authors:  Saar Anis; Corinne Zalomek; Amos D Korczyn; Alina Rosenberg; Nir Giladi; Tanya Gurevich
Journal:  Behav Neurol       Date:  2022-03-09       Impact factor: 3.342

Review 5.  Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature.

Authors:  Jessica Frey; Irene A Malaty
Journal:  Curr Neurol Neurosci Rep       Date:  2022-02-02       Impact factor: 6.030

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.